Global Brain Disease Market Research Report 2023

Report ID: 1989562 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Brain Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Brain Cancer
        1.2.3 Alzheimer Disease
        1.2.4 Alcoholism
        1.2.5 Amnesia
        1.2.6 Epilepsy
        1.2.7 Meningitis
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Brain Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals Pharmacy
        1.3.3 Online Pharmacy
        1.3.4 Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Brain Disease Market Perspective (2017-2028)
    2.2 Brain Disease Growth Trends by Region
        2.2.1 Brain Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Brain Disease Historic Market Size by Region (2017-2022)
        2.2.3 Brain Disease Forecasted Market Size by Region (2023-2028)
    2.3 Brain Disease Market Dynamics
        2.3.1 Brain Disease Industry Trends
        2.3.2 Brain Disease Market Drivers
        2.3.3 Brain Disease Market Challenges
        2.3.4 Brain Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Brain Disease Players by Revenue
        3.1.1 Global Top Brain Disease Players by Revenue (2017-2022)
        3.1.2 Global Brain Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Brain Disease Revenue
    3.4 Global Brain Disease Market Concentration Ratio
        3.4.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2021
    3.5 Brain Disease Key Players Head office and Area Served
    3.6 Key Players Brain Disease Product Solution and Service
    3.7 Date of Enter into Brain Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Disease Breakdown Data by Type
    4.1 Global Brain Disease Historic Market Size by Type (2017-2022)
    4.2 Global Brain Disease Forecasted Market Size by Type (2023-2028)
5 Brain Disease Breakdown Data by Application
    5.1 Global Brain Disease Historic Market Size by Application (2017-2022)
    5.2 Global Brain Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Brain Disease Market Size (2017-2028)
    6.2 North America Brain Disease Market Size by Country (2017-2022)
    6.3 North America Brain Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Brain Disease Market Size (2017-2028)
    7.2 Europe Brain Disease Market Size by Country (2017-2022)
    7.3 Europe Brain Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Brain Disease Market Size (2017-2028)
    8.2 Asia-Pacific Brain Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Brain Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Brain Disease Market Size (2017-2028)
    9.2 Latin America Brain Disease Market Size by Country (2017-2022)
    9.3 Latin America Brain Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Brain Disease Market Size (2017-2028)
    10.2 Middle East & Africa Brain Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Brain Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Brain Disease Introduction
        11.1.4 Pfizer Revenue in Brain Disease Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Detail
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Brain Disease Introduction
        11.2.4 Eli Lilly Revenue in Brain Disease Business (2017-2022)
        11.2.5 Eli Lilly Recent Development
    11.3 F. Hoffmann La Roche
        11.3.1 F. Hoffmann La Roche Company Detail
        11.3.2 F. Hoffmann La Roche Business Overview
        11.3.3 F. Hoffmann La Roche Brain Disease Introduction
        11.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2017-2022)
        11.3.5 F. Hoffmann La Roche Recent Development
    11.4 GE Healthcare
        11.4.1 GE Healthcare Company Detail
        11.4.2 GE Healthcare Business Overview
        11.4.3 GE Healthcare Brain Disease Introduction
        11.4.4 GE Healthcare Revenue in Brain Disease Business (2017-2022)
        11.4.5 GE Healthcare Recent Development
    11.5 Janssen Pharmaceuticals
        11.5.1 Janssen Pharmaceuticals Company Detail
        11.5.2 Janssen Pharmaceuticals Business Overview
        11.5.3 Janssen Pharmaceuticals Brain Disease Introduction
        11.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2017-2022)
        11.5.5 Janssen Pharmaceuticals Recent Development
    11.6 Abbvie
        11.6.1 Abbvie Company Detail
        11.6.2 Abbvie Business Overview
        11.6.3 Abbvie Brain Disease Introduction
        11.6.4 Abbvie Revenue in Brain Disease Business (2017-2022)
        11.6.5 Abbvie Recent Development
    11.7 AC Immune
        11.7.1 AC Immune Company Detail
        11.7.2 AC Immune Business Overview
        11.7.3 AC Immune Brain Disease Introduction
        11.7.4 AC Immune Revenue in Brain Disease Business (2017-2022)
        11.7.5 AC Immune Recent Development
    11.8 Allergan
        11.8.1 Allergan Company Detail
        11.8.2 Allergan Business Overview
        11.8.3 Allergan Brain Disease Introduction
        11.8.4 Allergan Revenue in Brain Disease Business (2017-2022)
        11.8.5 Allergan Recent Development
    11.9 Merck
        11.9.1 Merck Company Detail
        11.9.2 Merck Business Overview
        11.9.3 Merck Brain Disease Introduction
        11.9.4 Merck Revenue in Brain Disease Business (2017-2022)
        11.9.5 Merck Recent Development
    11.10 Novartis
        11.10.1 Novartis Company Detail
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Brain Disease Introduction
        11.10.4 Novartis Revenue in Brain Disease Business (2017-2022)
        11.10.5 Novartis Recent Development
    11.11 AstraZeneca
        11.11.1 AstraZeneca Company Detail
        11.11.2 AstraZeneca Business Overview
        11.11.3 AstraZeneca Brain Disease Introduction
        11.11.4 AstraZeneca Revenue in Brain Disease Business (2017-2022)
        11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Brain Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Brain Cancer
    Table 3. Key Players of Alzheimer Disease
    Table 4. Key Players of Alcoholism
    Table 5. Key Players of Amnesia
    Table 6. Key Players of Epilepsy
    Table 7. Key Players of Meningitis
    Table 8. Key Players of Others
    Table 9. Global Brain Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Brain Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Brain Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Brain Disease Market Share by Region (2017-2022)
    Table 13. Global Brain Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Brain Disease Market Share by Region (2023-2028)
    Table 15. Brain Disease Market Trends
    Table 16. Brain Disease Market Drivers
    Table 17. Brain Disease Market Challenges
    Table 18. Brain Disease Market Restraints
    Table 19. Global Brain Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Brain Disease Market Share by Players (2017-2022)
    Table 21. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Disease as of 2021)
    Table 22. Ranking of Global Top Brain Disease Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Brain Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Brain Disease Product Solution and Service
    Table 26. Date of Enter into Brain Disease Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Brain Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Brain Disease Revenue Market Share by Type (2017-2022)
    Table 30. Global Brain Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Brain Disease Revenue Market Share by Type (2023-2028)
    Table 32. Global Brain Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Brain Disease Revenue Market Share by Application (2017-2022)
    Table 34. Global Brain Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Brain Disease Revenue Market Share by Application (2023-2028)
    Table 36. North America Brain Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Brain Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Brain Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Brain Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Brain Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Brain Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Brain Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Brain Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Brain Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Brain Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Brain Disease Product
    Table 49. Pfizer Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. Eli Lilly Company Detail
    Table 52. Eli Lilly Business Overview
    Table 53. Eli Lilly Brain Disease Product
    Table 54. Eli Lilly Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 55. Eli Lilly Recent Development
    Table 56. F. Hoffmann La Roche Company Detail
    Table 57. F. Hoffmann La Roche Business Overview
    Table 58. F. Hoffmann La Roche Brain Disease Product
    Table 59. F. Hoffmann La Roche Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 60. F. Hoffmann La Roche Recent Development
    Table 61. GE Healthcare Company Detail
    Table 62. GE Healthcare Business Overview
    Table 63. GE Healthcare Brain Disease Product
    Table 64. GE Healthcare Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 65. GE Healthcare Recent Development
    Table 66. Janssen Pharmaceuticals Company Detail
    Table 67. Janssen Pharmaceuticals Business Overview
    Table 68. Janssen Pharmaceuticals Brain Disease Product
    Table 69. Janssen Pharmaceuticals Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 70. Janssen Pharmaceuticals Recent Development
    Table 71. Abbvie Company Detail
    Table 72. Abbvie Business Overview
    Table 73. Abbvie Brain Disease Product
    Table 74. Abbvie Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 75. Abbvie Recent Development
    Table 76. AC Immune Company Detail
    Table 77. AC Immune Business Overview
    Table 78. AC Immune Brain Disease Product
    Table 79. AC Immune Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 80. AC Immune Recent Development
    Table 81. Allergan Company Detail
    Table 82. Allergan Business Overview
    Table 83. Allergan Brain Disease Product
    Table 84. Allergan Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 85. Allergan Recent Development
    Table 86. Merck Company Detail
    Table 87. Merck Business Overview
    Table 88. Merck Brain Disease Product
    Table 89. Merck Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 90. Merck Recent Development
    Table 91. Novartis Company Detail
    Table 92. Novartis Business Overview
    Table 93. Novartis Brain Disease Product
    Table 94. Novartis Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 95. Novartis Recent Development
    Table 96. AstraZeneca Company Detail
    Table 97. AstraZeneca Business Overview
    Table 98. AstraZeneca Brain DiseaseProduct
    Table 99. AstraZeneca Revenue in Brain Disease Business (2017-2022) & (US$ Million)
    Table 100. AstraZeneca Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Brain Disease Market Share by Type: 2021 VS 2028
    Figure 2. Brain Cancer Features
    Figure 3. Alzheimer Disease Features
    Figure 4. Alcoholism Features
    Figure 5. Amnesia Features
    Figure 6. Epilepsy Features
    Figure 7. Meningitis Features
    Figure 8. Others Features
    Figure 9. Global Brain Disease Market Share by Application in 2021 & 2028
    Figure 10. Hospitals Pharmacy Case Studies
    Figure 11. Online Pharmacy Case Studies
    Figure 12. Pharmacy Case Studies
    Figure 13. Brain Disease Report Years Considered
    Figure 14. Global Brain Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Brain Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Brain Disease Market Share by Region: 2021 VS 2028
    Figure 17. Global Brain Disease Market Share by Players in 2021
    Figure 18. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Disease as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Brain Disease Revenue in 2021
    Figure 20. North America Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Brain Disease Market Share by Country (2017-2028)
    Figure 22. United States Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Brain Disease Market Share by Country (2017-2028)
    Figure 26. Germany Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Brain Disease Market Share by Region (2017-2028)
    Figure 34. China Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Brain Disease Market Share by Country (2017-2028)
    Figure 42. Mexico Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Brain Disease Market Share by Country (2017-2028)
    Figure 46. Turkey Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Brain Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Pfizer Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 49. Eli Lilly Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 50. F. Hoffmann La Roche Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 51. GE Healthcare Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 52. Janssen Pharmaceuticals Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 53. Abbvie Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 54. AC Immune Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 55. Allergan Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 58. AstraZeneca Revenue Growth Rate in Brain Disease Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca
Frequently Asked Questions
Brain Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Brain Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Brain Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Brain Forceps

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More